Seraphim Space Index Q2 2020 – sector showing resilience

Written by: Seraphim Capital

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” column_border_width=”none” column_border_style=”solid” bg_image_animation=”none”][vc_column_text]

We were eager to see the 30th June 2020 figures for the Seraphim Space Index to better understand the impact of the Covid pandemic on the appetite for venture investment in the global space technology domain.

The Q2 2020 total investment was $672m including $346m investment into SpaceX. Compared to Q2 2019, which also included a sizeable $536m SpaceX investment, the Q2 20 investment saw an increase of 12%. Investment gains across most sub-categories led by a 5 fold increase in constellation investment at $173m, with Analysis and Product categories up by 191% and 31% respectively. Two categories saw declines Launch and Downlink both falling by 29% to $384m and $13m respectively.

Regionally US investment was down by 15% to $492m whilst investment in Asian companies was buoyant increasing 3 fold to $89m, followed by European investment up by 68%.

Investment across the Early Stages saw a positive increase with Seed up 73%, A series 56%, B series 35% whilst Growth Stage investments were flat, down by just 1%.

Capital concentration Q2 2020 versus Q2 2019 were consistent. After allowing for outliers SpaceX and Oneweb investment the next top 5 investments in Q2 2020 accounted for 27% of all investment versus 32% the year earlier. In relation to the top 10 investments, they accounted for 47% of total investment across both quarters.

Looking at the rolling full year figures to 30th June 2020 a total of $4.31bn was invested in the year compared against $4.07m in the previous year. Removing associated HAPS/UAV related investments the space specific headline was $3.16bn which was 12% down Y-o-Y. This included $846m Investment into industry bell weather SpaceX versus $809m the previous year.

From a sector category perspective Launch remained the focus for VC investors totalling $1.35bn over the year, up by 7% Y-o-Y.  Also ahead was investment into companies that undertake Analysis of satellite data which nearly doubled to $235m. Companies that incorporate satellite data into their Products nearly tripled to $464m. Headline investment into satellite constellations fell by 46% to $901m. However, the 2019 data included a $1.25bn investment in the recently troubled broadband internet startup OneWeb. Removing this as an outlier reveals that the underlying investment into constellations was buoyant, more than doubling the previous years figure.  The hardest hit category was Build, the companies making components and/or building satellites which fell by 57% to $83m.

Regionally, total investment into US based companies fell by 20% Y-o-Y to $2.29bn. However, after removing the OneWeb outlier US investment actually increased by a healthy 43%. Investors stepped up their commitment to European companies increasing their Y-o-Y investment by 56% to $276m followed by Asian companies accessing 25% more investment across the year totalling $531m.

Y-o-Y investment across Early Stage saw a positive increase with Seed up 172%, A series 21%, B series 55% whilst C series saw a 5 fold increase to $435m. At the headline level growth investment in later stages fell by 51% to $1.2bn, however, again the OneWeb outlier into account the level of growth staged investment was flat, down by just 2%.

Overall the spacetech sector has demonstrated resilience in the face of Covid – despite this we still remain cautious on the overall outlook for VC investment in the sector for the 2H 2020.

[/vc_column_text][/vc_column][/vc_row]

Important Information

The information contained on this website is intended only for investors who are resident in the United Kingdom who are not US Persons (as defined in the US Securities Act of 1933, as amended) (“US Persons”) and may not be accessed by persons who are located in the United States, Canada, Australia, Japan, any member state of the EEA or the Republic of South Africa. Viewing the materials you are seeking to access may not be lawful in jurisdictions other than the United Kingdom.

The information on this website is for information purposes only and does not constitute or form a part of any offer or invitation to sell or issue, or the solicitation of any offer to purchase or subscribe for, securities. The information on this website is general in nature and does not in any way constitute investment, tax, legal or other advice. If you are unsure as to whether the investments described on this site are suitable for you, we strongly recommend that you seek professional advice from a financial adviser before making any investment or financial decisions.

No securities of Seraphim Space Investment Trust plc (the “Company”) have been or will be registered under the US Securities Act of 1933, as amended (the “Securities Act”) or under the securities laws of any state or other jurisdiction of the United States and may not be offered, sold or delivered, directly or indirectly, in or into the United States, or to or for the account or benefit of any US Person except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. In addition, the Company has not been, and will not be, registered under the United States Investment Company Act of 1940, as amended. There will be no public offer of securities in the United States.

If you are not permitted to view this website or are in any doubt as to whether you are permitted to view this website, please exit this website immediately by clicking on the “Disagree” button below. The contents of this website must not be released or otherwise forwarded, distributed or sent, directly or indirectly, in whole or in part, outside the United Kingdom and in particular in or into the United States, Australia, Canada, the Republic of South Africa, any member state of the EEA, Japan or any other jurisdiction where the distribution of such materials would or may breach any applicable law or regulation or would require any registration or licensing within such jurisdiction. Persons receiving any such materials (including, without limitation, custodians, nominees and trustees) should observe these restrictions and must not, directly or indirectly, in whole or in part, forward, distribute or send them in, into or from any jurisdiction outside the United Kingdom. None of the Company, its directors, Seraphim Space (Manager) LLP (“Seraphim”) or any of their respective advisers accept any responsibility for any violation by any person of any of these restrictions.

In addition, the securities referred to on this website may only be offered in member states of the European Economic Area (each a “Relevant State”) to the extent that such securities (i) are permitted to be marketed into the jurisdiction of the Relevant State pursuant to the Alternative Investment Fund Managers Directive 2011/61/EU; or (ii) can otherwise be lawfully offered or sold (including on the basis of an unsolicited request from a professional investor (as that term is used in the Alternative Investment Fund Managers Directive 2011/61/EU)).

The information on this website is general in nature and may be subject to amendment and updating without notice. None of the Company, its directors, Seraphim or any other person guarantees the accuracy or completeness of any information on this website or accepts any responsibility or duty to update any information, document or announcement contained on this website, and each such person disclaims all representations and warranties, whether express or implied, to the greatest extent permitted by applicable law and regulation. By continuing to use this website, you agree to the exclusion by such persons, to the greatest extent permitted by applicable law and regulation, of any and all liability for any direct, indirect, punitive, consequential, incidental, special or other damages, including, without limitation, loss of profits, revenue or data arising out of or relating to the provision of and your use of this website and its content.

None of the Company, its directors, Seraphim or any other person accepts any responsibility in respect of any information contained on any other website which may be linked to or from this website.

This website is governed by the laws of England.

By clicking the “I accept” button below, you confirm, represent and warrant to the Company, its directors and Seraphim that you are located in the United Kingdom, you are not a US Person and you are not a resident of, or physically present in, the United States, Canada, Australia, Japan, any member of the state of the EEA or the Republic of South Africa or any other territory where to do so would breach applicable laws, rules or regulations; you are not investing or otherwise acting for the account or benefit of a US Person or a resident of the United States or Canada, Australia, Japan, any member of the state of the EEA or the Republic of South Africa or any other territory where to do so would breach applicable laws, rules or regulations; you are accessing this website for information purposes only; you have read, understood and agree to the disclaimer above; and you agree that you will not transmit or otherwise send any of the information on this website to persons outside the United Kingdom, including to any persons in the United States or to publications with a general circulation in the United States.